WILLIAM COLEMAN: Open Payments
NPI 1134157381 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84 in 3 payments from 3 companies in 2025. Trend: 2023 $17 · 2024 $156 · 2025 $84
Food & beverage: $84
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Braeburn Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: REXULTI, BRIXADI, INGREZZA.
Industry payments across GA — which companies pay providers there.
